Tesla
TSLA
Apple
AAPL
Taylor Morrison Home
TMHC
Amazon
AMZN
D.R. Horton
DHI
US Stock MarketDetailed Quotes
MIST Milestone Pharmaceuticals
- 2.305
- +0.295+14.68%
Trading Mar 27 14:53 ET
122.98MMarket Cap-3.44P/E (TTM)
2.340High2.030Low5.44MVolume2.240Open2.010Pre Close11.97MTurnover10.26%Turnover RatioLossP/E (Static)53.35MShares2.75052wk High9.37P/B122.18MFloat Cap1.12052wk Low--Dividend TTM53.00MShs Float27.950Historical High--Div YieldTTM15.42%Amplitude1.120Historical Low2.201Avg Price1Lot Size
Milestone Pharmaceuticals News
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nelson Jeffrey Edward
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Oliveto Joseph
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bharucha David
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hasija Amit
Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(5.2%),Millennium Group Management LLC(5.2%), etc.
Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director PAPA JOSEPH C
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PAPA JOSEPH C
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Saik Andrew
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Giles Lisa M.
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fischer Seth H. Z.
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director TOMSICEK MICHAEL JOHN
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Saik Andrew
Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Saik Andrew
Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Duty Stuart
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duty Stuart
Milestone Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alta Fundamental Advisers LLC(4.99%),Gilbert Li(4.99%), etc.
Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(2.8%),VHCP Co-Investment Holdings III, LLC(2.8%), etc.
Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
Milestone Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(4.1 %),GOLDMAN SACHS & CO. LLC(4.1 %)
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.